Merit Medical Systems

Rank: 73
2016 Rank84
Employees4,150
Revenue:$603,838,000
R&D Spend:$45,229,000
Fiscal year ending:12-31-16
Click here to see all 100

Merit’s primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.

Merit Medical Announces 510(k) Clearance for Corvocet Biopsy System. Merit Medical Acquires the HeROGraft From CryoLife, Inc.

Big 100 Mini Logo Key Personnel: Fred Lampropoulos, chairman & CEO; Bernard Birkett, CFO; Joe Wright, president, int'l sales; Darla Gill, president, Merit Endotek; Ronald Frost, COO; Brian Lloyd, chief legal officer & corporate secretary; Justin Lampropoulos, EVP, U.S., EMEA, global marketing & strategy; John Knorpp, chief regulatory affairs officer; Joseph Pierce, CIO; Louise Bott, VP, global HR; Jason Treft, CTO;

1600 West Merit Parkway
South Jordan, Utah
84095
USA